Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.
A California federal jury found Friday that an attorney interfered with multiple domain names belonging to securities boutique Trowbridge Sidoti LLP after she claimed ownership following her exit from the firm, but found that her refusal to relinquish just one of the domain names caused harm, awarding only $7,800 in damages.
The Patent Trial and Appeal Board ruled Friday that tribal sovereign immunity does not apply to inter partes reviews and dismissed a motion from the Saint Regis Mohawk Tribe to toss generics companies' challenges to patents for the dry-eye drug Restasis, which Allergan Inc. sold to the tribe last year.
The U.S. Patent and Trademark Office recently revised its Manual of Patent Examining Procedure for the first time in over two years, adding new material about patent-eligibility, the duty to disclose information to the office and other key patent law issues. Here’s what attorneys should know about the update.
So far in February, Alston & Bird LLP lost an FDA-focused attorney to Goodwin Procter LLP and gained a government contracts attorney from Dentons, and intellectual property boutique Lucas & Mercanti LLP announced the arrival of three attorneys specializing in pharma.
A top U.S. Department of Justice antitrust official said Friday in a London speech that despite the rapid pace of change in the data and tech landscape, open-minded, evidence-based enforcement remains the crucial ingredient to prevent governments from harming innovation and consumers.